ALEXANDRIA, Va., July 23 -- United States Patent no. 12,364,743, issued on July 22, was assigned to ENTEROME S.A. (Paris).
"Microbiota sequence variants of tumor-related antigenic epitopes" was invented by Laurent Chene (Neuville aux Bois, France), Alessandra Cervino (Bois-le-Roi, France), Francesco Strozzi (Paris), Celia Mendez (Charlestown, Mass.) and Christophe Bonny (Paris).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to cancer immunotherapy, in particular to sequence variants of tumor-related antigenic epitope sequences. Namely, the present invention provides a method for identification of microbiota sequence variants of tumor-related antigenic epitope sequences. Such micr...